Galapagos NV (GLPG) stock Forecast for 2022 – 2026

Galapagos NV (GLPG) stock Forecast for 2022 – 2026

Last update: 05-28-2022, 13:51

Sector: Healthcare

The share price of Galapagos NV (GLPG) now

What analysts predict:: $74.4

52-week high/low: $81.12 / $46.41

50/200 Day Moving Average: $62.19 / $57.67

This figure corresponds to the average price over the previous 50/200 days. For Galapagos NV stocks, the 50-day moving average is the resistance level today.

For Galapagos NV stocks, the 200-day moving average is the resistance level today.

Are you interested in Galapagos NV stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Galapagos NV stock price in 2022, 2023, 2024, 2025, 2026. How much will one Galapagos NV share be worth in 2022 - 2026?

When should I take profit in Galapagos NV stock? When should I record a loss on Galapagos NV stock? What are analysts' forecasts for Galapagos NV stock? What is the future of Galapagos NV stock?

We forecast Galapagos NV stock performance using neural networks based on historical data on Galapagos NV stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Galapagos NV stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Galapagos NV shares. This happens once a day.




Historical and forecast chart of Galapagos NV stock

The chart below shows the historical price of Galapagos NV stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Galapagos NV stock price can be found in the table below.

Long-term forecasts by years.

Galapagos NV daily forecast for a month

Date Target Pes. Opt. Vol., %
May 30 59.44 58.67 60.19 2.59
May 31 60.06 59.22 61.22 3.37
Jun 01 57.96 56.87 59.56 4.74
Jun 02 58.73 57.91 60.11 3.80
Jun 03 58.07 57.24 58.77 2.66
Jun 04 58.14 57.59 59.54 3.39
Jun 05 58.64 57.37 60.16 4.87
Jun 06 58.01 56.73 59.17 4.29
Jun 07 59.29 58.66 59.95 2.19
Jun 08 57.69 57.04 59.30 3.96
Jun 09 57.16 56.46 57.58 1.98
Jun 10 58.33 57.61 59.30 2.94
Jun 11 57.37 55.78 58.69 5.22
Jun 12 58.31 57.37 59.27 3.31
Jun 13 58.29 57.11 58.92 3.18
Jun 14 58.76 58.04 59.58 2.66
Jun 15 59.72 58.07 60.52 4.21
Jun 16 60.56 59.67 60.98 2.20
Jun 17 59.71 59.23 61.13 3.21
Jun 18 57.69 56.49 58.51 3.57
Jun 19 58.17 57.13 58.92 3.14
Jun 20 56.60 55.77 57.69 3.45
Jun 21 56.48 54.92 57.67 5.00
Jun 22 57.31 55.81 58.44 4.71
Jun 23 59.20 58.02 60.11 3.61
Jun 24 60.69 59.12 62.28 5.35
Jun 25 59.20 57.80 60.01 3.84
Jun 26 58.35 57.44 59.56 3.70
Jun 27 58.50 57.86 58.95 1.88
Jun 28 59.05 57.96 60.31 4.07

Galapagos NV Daily Price Targets


Galapagos NV Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $59.44. Positive dynamics for Galapagos NV shares will prevail with possible volatility of 2.523%.

Pessimistic target level: 58.67

Optimistic target level: 60.19


Galapagos NV Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $60.06. Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.262%.

Pessimistic target level: 59.22

Optimistic target level: 61.22


Galapagos NV Stock Forecast 06-01-2022.

Forecast target price for 06-01-2022: $57.96. Negative dynamics for Galapagos NV shares will prevail with possible volatility of 4.530%.

Pessimistic target level: 56.87

Optimistic target level: 59.56


Galapagos NV Stock Forecast 06-02-2022.

Forecast target price for 06-02-2022: $58.73. Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.659%.

Pessimistic target level: 57.91

Optimistic target level: 60.11


Galapagos NV Stock Forecast 06-03-2022.

Forecast target price for 06-03-2022: $58.07. Negative dynamics for Galapagos NV shares will prevail with possible volatility of 2.594%.

Pessimistic target level: 57.24

Optimistic target level: 58.77


Galapagos NV Stock Forecast 06-04-2022.

Forecast target price for 06-04-2022: $58.14. Positive dynamics for Galapagos NV shares will prevail with possible volatility of 3.281%.

Pessimistic target level: 57.59

Optimistic target level: 59.54


GLPG (GLPG) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 61.16 54.41 65.07 16.39
Jul. 65.95 60.78 69.64 12.73
Aug. 63.74 56.50 68.53 17.56
Sep. 68.63 65.67 71.92 8.70
Oct. 72.58 67.94 77.69 12.56
Nov. 81.53 73.18 84.27 13.16
Dec. 90.92 86.84 96.15 9.68

Galapagos NV forecast for this year


Galapagos NV Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $61.1568. Pessimistic: $54.41. Optimistic: $65.07


Galapagos NV Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $65.9515. Pessimistic: $60.78. Optimistic: $69.64


Galapagos NV Stock Prediction for Aug 2022

An downtrend is forecast for this month with an optimal target price of $63.7355. Pessimistic: $56.50. Optimistic: $68.53


Galapagos NV Stock Prediction for Sep 2022

An uptrend is forecast for this month with an optimal target price of $68.6304. Pessimistic: $65.67. Optimistic: $71.92


Galapagos NV Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $72.5835. Pessimistic: $67.94. Optimistic: $77.69


Galapagos NV Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $81.5258. Pessimistic: $73.18. Optimistic: $84.27


Galapagos NV Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $90.9176. Pessimistic: $86.84. Optimistic: $96.15




Galapagos NV (GLPG) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 85.39 75.01 90.58 17.19
Feb 78.70 73.41 87.51 16.12
Mar 86.25 82.25 90.94 9.56
Apr 78.25 69.48 87.26 20.37
May 78.50 69.33 83.65 17.12
Jun 80.76 77.66 91.09 14.75
Jul 83.08 75.11 90.79 17.28
Aug 86.27 79.65 89.31 10.82
Sep 86.96 77.92 91.14 14.50
Oct 91.00 87.07 98.57 11.67
Nov 103.52 94.08 115.28 18.39
Dec 102.03 89.95 110.36 18.49

Galapagos NV (GLPG) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 108.40 97.47 111.87 12.87
Feb 91.05 86.39 100.23 13.81
Mar 90.47 79.90 99.30 19.53
Apr 87.57 83.09 93.88 11.49
May 81.27 76.72 87.77 12.59
Jun 75.68 70.11 83.31 15.84
Jul 84.76 79.20 89.51 11.52
Aug 80.42 74.50 89.68 16.93
Sep 82.09 73.69 87.35 15.64
Oct 70.93 61.85 78.76 21.47
Nov 73.42 67.55 78.95 14.43
Dec 78.01 71.27 84.62 15.78



Galapagos NV (GLPG) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 89.74 82.13 92.75 11.46
Feb 94.91 90.81 98.86 8.14
Mar 103.11 99.31 115.65 14.12
Apr 118.95 105.24 131.51 19.97
May 111.14 98.52 122.17 19.36
Jun 113.10 106.22 117.26 9.41
Jul 126.67 113.09 140.86 19.71
Aug 132.14 127.70 141.66 9.85
Sep 134.26 126.52 145.21 12.87
Oct 122.87 108.32 126.80 14.57
Nov 116.97 103.87 120.72 13.95
Dec 111.55 100.30 115.29 13.00

Galapagos NV (GLPG) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 125.82 113.95 135.49 15.90
Feb 131.26 118.24 146.59 19.34
Mar 139.66 126.70 144.13 12.09
Apr 138.32 129.69 146.29 11.35
May 129.91 119.10 137.81 13.57
Jun 131.57 116.63 138.73 15.93
Jul 139.78 127.03 156.33 18.74
Aug 135.31 120.16 148.52 19.10
Sep 134.88 126.89 148.47 14.53
Oct 127.54 116.32 143.46 18.92
Nov 129.38 113.23 144.49 21.63
Dec 117.37 104.79 130.14 19.48

Galapagos NV information and performance

Galapagos NV, a clinical stage biotechnology company, discovers, develops and markets various small molecule drugs. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for rheumatoid arthritis, Crohn’s disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjögren’s syndrome, ankylosing spondylitis, psoriatic arthritis, cutaneous lupus erythematosus, membranous nephropathy lupus and uveitis.

Galapagos NV Address

GEN DE WITTELAAN L11 A3, 2800 MECHELEN, BE

Market Capitalization: 3 612 620 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.03

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 20.54

Quarterly Revenue Growth YOY: 0.197

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.184

Enterprise Value (EV) /Revenue

EV To EBITDA: 16.11

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 65648000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.